These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15245774)

  • 21. Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ.
    Rice A; Liu Y; Michaelis ML; Himes RH; Georg GI; Audus KL
    J Med Chem; 2005 Feb; 48(3):832-8. PubMed ID: 15689167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The blood-brain barrier: implications for chemotherapy in brain tumors].
    Boaziz C; Breau JL; Morère JF; Israël L
    Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors.
    Haluska M; Anthony ML
    Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
    Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral paclitaxel chemotherapy for brain tumors: ideal combination treatment of paclitaxel and P-glycoprotein inhibitor.
    Joo KM; Park K; Kong DS; Song SY; Kim MH; Lee GS; Kim MS; Nam DH
    Oncol Rep; 2008 Jan; 19(1):17-23. PubMed ID: 18097571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].
    Prange HW; Nau R
    Zentralbl Neurochir; 1997; 58(3):127-33. PubMed ID: 9446463
    [No Abstract]   [Full Text] [Related]  

  • 27. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Temporary hyperosmolar breakage of the blood-brain barrier improves effectiveness of chemotherapy for cerebral tumors].
    Aronov MS; Kobiakov GL; Lubnin AIu; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (3):52-9. PubMed ID: 19062597
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
    Preston E; Slinn J; Vinokourov I; Stanimirovic D
    J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice.
    Gallo JM; Li S; Guo P; Reed K; Ma J
    Cancer Res; 2003 Aug; 63(16):5114-7. PubMed ID: 12941842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of P-glycoprotein activity at the primate blood-brain barrier increases the distribution of nelfinavir into the brain but not into the cerebrospinal fluid.
    Kaddoumi A; Choi SU; Kinman L; Whittington D; Tsai CC; Ho RJ; Anderson BD; Unadkat JD
    Drug Metab Dispos; 2007 Sep; 35(9):1459-62. PubMed ID: 17591677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?
    Sabel M; Rommel F; Kondakci M; Gorol M; Willers R; Bilzer T
    Lasers Surg Med; 2003; 33(2):75-80. PubMed ID: 12913878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-brain barrier imaging and therapeutic potentials.
    Rebeles F; Fink J; Anzai Y; Maravilla KR
    Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The decrease of paclitaxel efflux by pretreatment of interferon-γ and tumor necrosis factor-α after intracerebral microinjection.
    Lee NY; Kang YS
    Brain Res; 2013 Mar; 1499():158-62. PubMed ID: 23313612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.